Search - tctmd.com

Displaying 1 - 20 of 85

Sort: Relevancy | Date

Presentation TCT 2025

The APTURE Transcatheter Shunt: Technology Demonstration and Rationale of the ALT FLOW II Trial 8:23 AM – 8:30 AM PDT

Presenter: Dean J. Kereiakes

October 28, 2025

Presentation TCT 2024

Welcome, Clinical Rationale of Bioadaptive PCI

Presenter: Dean Kereiakes

October 30, 2024

Presentation TCT 2024

The Weight of a Lifetime of Lead: My Personal Journey Through Radiation Exposure

Presenter: Dean Kereiakes

October 28, 2024

Presentation TCT 2020

OPTIMIZE: A Randomized Trial of a Novel, Ultra Low Profile Fixed-Wire DES

Presenter: Dean Kereiakes

October 17, 2020

The OPTIMIZE IDE: TrialProspective, Randomized Evaluation of Sirolimus-Eluting Coronary Stents with Fixed-Wire and Rapid-Exchange Delivery Systems and a Novel Bioresorbable Drug Carrier

Presentation TCT 2020

OPTIMIZE IDE: Trial Prospective, Randomized Evaluation of Sirolimus-Eluting Coronary Stents with Fixed-Wire and Rapid-Exchange Delivery Systems and a Novel Bioresorbable Drug Carrier

Presenter: Dean J. Kereiakes

October 17, 2020

Presentation TCT 2020

Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Artery Disease: The Disrupt CAD III Study

Presenter: Dean J. Kereiakes

October 15, 2020

Presentation Cardiovascular Interventions 2019

DAPT: Hot Topics in 2019

Presenter: Dean J. Kereiakes

November 01, 2019

Presentation SIF 2019

Left Main Coronary Revascularization at the Crossroads: The Evolving Role of PCI

Presenter: Dean J. Kereiakes

March 28, 2019

Presentation SIF 2019

Novel Coronary Stent Platforms: Innovations to Improve Clinical Outcomes

Presenter: Dean J. Kereiakes

March 28, 2019

Presentation Cardiovascular Interventions 2018

DAPT in Evolution: 2018

Presenter: Dean J. Kereiakes

October 26, 2018

Presentation TCT 2018

ABSORB Beyond 3 Years: ABSORB III 4-Year Data

Presenter: Bernard R. Chevalier, Stephen G. Ellis, Dean J. Kereiakes

September 22, 2018

Presentation TCT 2018

TCT-61: Clinical Outcomes Following Complete Bioresorption of the Absorb Everolimus-Eluting Bioresorbable Scaffold: Four-year Results from the ABSORB III Trial

Presenter: Antonio L. Bartorelli, David G. Rizik, Dean J. Kereiakes

September 21, 2018

Presentation Cardiovascular Interventions 2017

BP-DES Update: SYNERGY and Beyond

Presenter: Dean J. Kereiakes

November 10, 2017

Presentation Cardiovascular Interventions 2017

DAPT Duration After Stenting: An Updated Appraisal

Presenter: Dean J. Kereiakes

November 09, 2017

Presentation TCT 2017

ABSORB IV 30-Day Results: Is Improved Technique Reflected in Superior Early Outcomes?

Presenter: Azeem Latib, Dean J. Kereiakes

October 31, 2017

Presentation TCT 2017

Expanding Clinical Evidence With SYNERGY: From EVOLVE II to Real-world Registries and EVOLVE DAPT

Presenter: Ioannis Iakovou, Gert Richardt, Dean J. Kereiakes

October 30, 2017

Presentation TCT 2017

Mortality and Stroke After PCI vs CABG In Left Main and 3VD: An Individual Patient Data Meta-analysis

Presenter: Dean J. Kereiakes, Spencer B. King III, A. Pieter Kappetein

October 30, 2017

Presentation TCT 2017

Influence of Diversity: Should Sex, Race, and Ethnicity Affect Revascularization Decisions? Does It?

Presenter: Dean J. Kereiakes, Spencer B. King III, Roxana Mehran

October 30, 2017

Presentation TCT 2017

Impact of Mandatory Stent Price Controls 2: My New Insights From Inside Industry

Presenter: Dean J. Kereiakes, Spencer B. King III, Ian T. Meredith

October 30, 2017

Presentation TCT 2017

Impact of Mandatory Stent Price Controls 1: Physician Perspectives

Presenter: Dean J. Kereiakes, Spencer B. King III, Upendra Kaul

October 30, 2017

Advertisement

The APTURE Transcatheter Shunt: Technology Demonstration and Rationale of the ALT FLOW II Trial 8:23 AM – 8:30 AM PDT

Welcome, Clinical Rationale of Bioadaptive PCI

The Weight of a Lifetime of Lead: My Personal Journey Through Radiation Exposure

OPTIMIZE: A Randomized Trial of a Novel, Ultra Low Profile Fixed-Wire DES

OPTIMIZE IDE: Trial Prospective, Randomized Evaluation of Sirolimus-Eluting Coronary Stents with Fixed-Wire and Rapid-Exchange Delivery Systems and a Novel Bioresorbable Drug Carrier

Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Artery Disease: The Disrupt CAD III Study

DAPT: Hot Topics in 2019

Left Main Coronary Revascularization at the Crossroads: The Evolving Role of PCI

Novel Coronary Stent Platforms: Innovations to Improve Clinical Outcomes

DAPT in Evolution: 2018

ABSORB Beyond 3 Years: ABSORB III 4-Year Data

TCT-61: Clinical Outcomes Following Complete Bioresorption of the Absorb Everolimus-Eluting Bioresorbable Scaffold: Four-year Results from the ABSORB III Trial

BP-DES Update: SYNERGY and Beyond

DAPT Duration After Stenting: An Updated Appraisal

ABSORB IV 30-Day Results: Is Improved Technique Reflected in Superior Early Outcomes?

Expanding Clinical Evidence With SYNERGY: From EVOLVE II to Real-world Registries and EVOLVE DAPT

Mortality and Stroke After PCI vs CABG In Left Main and 3VD: An Individual Patient Data Meta-analysis

Influence of Diversity: Should Sex, Race, and Ethnicity Affect Revascularization Decisions? Does It?

Impact of Mandatory Stent Price Controls 2: My New Insights From Inside Industry

Impact of Mandatory Stent Price Controls 1: Physician Perspectives

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content